0000899243-22-027631.txt : 20220803
0000899243-22-027631.hdr.sgml : 20220803
20220803174808
ACCESSION NUMBER: 0000899243-22-027631
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220801
FILED AS OF DATE: 20220803
DATE AS OF CHANGE: 20220803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chung Wendy
CENTRAL INDEX KEY: 0001922605
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40693
FILM NUMBER: 221133913
MAIL ADDRESS:
STREET 1: PRIME MEDICINE, INC.
STREET 2: 21 ERIE ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rallybio Corp
CENTRAL INDEX KEY: 0001739410
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851083789
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 234 CHURCH STREET
STREET 2: SUITE 1020
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203- 859-3820
MAIL ADDRESS:
STREET 1: 234 CHURCH STREET
STREET 2: SUITE 1020
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
FORMER COMPANY:
FORMER CONFORMED NAME: Rallybio Holdings, LLC
DATE OF NAME CHANGE: 20180502
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-01
0
0001739410
Rallybio Corp
RLYB
0001922605
Chung Wendy
C/O RALLYBIO CORPORATION
234 CHURCH STREET, SUITE 1020
NEW HAVEN
CT
06510
1
0
0
0
Option (Right to Buy)
9.11
2022-08-01
4
A
0
26880
0.00
A
2032-08-01
Common Stock
26880
26880
D
The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in three equal annual installments beginning on August 1, 2023.
/s/ Michael Greco, Attorney-in-Fact
2022-08-03